Cas no 1542024-47-4 (4-Bromo-1-chloro-8-fluoroisoquinoline)
4-Bromo-1-chloro-8-fluoroisoquinoline Chemical and Physical Properties
Names and Identifiers
-
- 4-BROMO-1-CHLORO-8-FLUOROISOQUINOLINE
- 4-Bromo-1-chloro-8-fluoroisoquinoline
-
- Inchi: 1S/C9H4BrClFN/c10-6-4-13-9(11)8-5(6)2-1-3-7(8)12/h1-4H
- InChI Key: VCQKAKNGDZTZHD-UHFFFAOYSA-N
- SMILES: BrC1=CN=C(C2C(=CC=CC=21)F)Cl
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 0
- Complexity: 193
- XLogP3: 3.9
- Topological Polar Surface Area: 12.9
4-Bromo-1-chloro-8-fluoroisoquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B204025-50mg |
4-Bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 50mg |
$ 420.00 | 2022-06-01 | ||
| TRC | B204025-100mg |
4-Bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 100mg |
$ 700.00 | 2022-06-01 | ||
| Enamine | EN300-397961-0.05g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 0.05g |
$322.0 | 2023-03-02 | |
| Enamine | EN300-397961-0.1g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 0.1g |
$481.0 | 2023-03-02 | |
| Enamine | EN300-397961-0.25g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 0.25g |
$686.0 | 2023-03-02 | |
| Enamine | EN300-397961-0.5g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 0.5g |
$1081.0 | 2023-03-02 | |
| Enamine | EN300-397961-1.0g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 1g |
$0.0 | 2023-06-07 | |
| Enamine | EN300-397961-2.5g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 2.5g |
$2716.0 | 2023-03-02 | |
| Enamine | EN300-397961-5.0g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 5.0g |
$4018.0 | 2023-03-02 | |
| Enamine | EN300-397961-10.0g |
4-bromo-1-chloro-8-fluoroisoquinoline |
1542024-47-4 | 95% | 10.0g |
$5959.0 | 2023-03-02 |
4-Bromo-1-chloro-8-fluoroisoquinoline Related Literature
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
-
Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
Additional information on 4-Bromo-1-chloro-8-fluoroisoquinoline
4-Bromo-1-chloro-8-fluoroisoquinoline: A Comprehensive Overview
The compound 4-Bromo-1-chloro-8-fluoroisoquinoline (CAS No. 1542024-47-4) is a highly specialized heterocyclic aromatic compound belonging to the isoquinoline family. This molecule is characterized by its unique structure, which includes a fused benzene and pyridine ring system, with substituents at positions 1, 4, and 8. The presence of bromine, chlorine, and fluorine atoms introduces significant electronic and steric effects, making this compound a valuable substrate for various chemical transformations and applications.
Recent advancements in synthetic chemistry have highlighted the importance of halogenated isoquinolines in drug discovery and materials science. The bromine, chlorine, and fluorine substituents in 4-Bromo-1-chloro-8-fluoroisoquinoline not only enhance its reactivity but also provide opportunities for selective functionalization. For instance, the bromine atom at position 4 can serve as a leaving group in nucleophilic substitution reactions, enabling the introduction of diverse functional groups. Similarly, the chlorine at position 1 and the fluorine at position 8 can participate in π-interactions or act as directing groups in further synthetic steps.
One of the most promising applications of this compound lies in its potential as an intermediate in the synthesis of bioactive molecules. Recent studies have demonstrated that isoquinoline derivatives with halogen substituents exhibit potent anti-tumor activity. For example, researchers have reported that halogenated isoquinolines can inhibit key enzymes involved in cancer cell proliferation, such as cyclin-dependent kinases (CDKs). The combination of bromine, chlorine, and fluorine in 4-Bromo-1-chloro-8-fluoroisoquinoline may synergistically enhance its bioactivity, making it a compelling candidate for further exploration in oncology research.
In addition to its biological applications, this compound has also garnered attention in the field of materials science. The rigid aromatic framework of isoquinoline derivatives makes them ideal candidates for constructing π-conjugated materials with unique electronic properties. The presence of halogens can further modulate the electronic characteristics of the molecule, potentially leading to applications in organic electronics or optoelectronics. For instance, recent studies have explored the use of halogenated isoquinolines as building blocks for designing advanced organic semiconductors with tailored charge transport properties.
The synthesis of 4-Bromo-1-chloro-8-fluoroisoquinoline typically involves a multi-step process that combines traditional organic synthesis techniques with modern catalytic methods. A common approach involves the Friedlander synthesis pathway, where an o-amino aryl ketone undergoes cyclization to form the isoquinoline core. Subsequent halogenation steps are then employed to introduce bromine, chlorine, and fluorine atoms at specific positions. Recent advancements in catalytic halogenation methods have significantly improved the efficiency and selectivity of these transformations.
From an analytical standpoint, this compound is well-characterized using a variety of spectroscopic techniques. High-resolution mass spectrometry (HRMS) confirms its molecular formula (C9H5BrClF), while nuclear magnetic resonance (NMR) spectroscopy provides detailed insights into its structural arrangement. X-ray crystallography has also been employed to determine its three-dimensional conformation, revealing a planar geometry consistent with aromaticity.
In terms of stability and handling, 4-Bromo-1-chloro-8-fluoroisoquinoline is generally stable under ambient conditions but should be stored away from light and moisture to prevent degradation. Its solubility properties make it suitable for various organic solvents commonly used in chemical synthesis.
Looking ahead, the versatility of this compound positions it as a valuable tool for researchers across multiple disciplines. Its ability to undergo a wide range of chemical transformations while retaining its core heterocyclic framework makes it an attractive candidate for both fundamental studies and applied research. As ongoing investigations continue to uncover new applications for halogenated isoquinolines, compounds like 4-Bromo-1-chloro-8-fluoroisoquinoline are likely to play an increasingly important role in advancing modern chemistry.
1542024-47-4 (4-Bromo-1-chloro-8-fluoroisoquinoline) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)